Tracking the Elusive Lymphocyte: Methods of Detection during Adoptive Immunotherapy

REFERENCES

• Agger R., Petersen M. S., Petersen C. C., Hansen S. B., Stodkilde-Jorgensen H., Skands U., Blankenstein T., Andersen T. E., Hulgaard E. F., Jorgensen J. T., Marqversen J., Gundersen H. J., Hokland M. E. T cell homing to tumors detected by 3D-coordinated positron emission tomography and magnetic resonance imaging. J. Immunother. 2007; 30: 29–39
   Google Scholar
• Ashley D. M., Bol S. J., Waugh C., Kannourakis G. A novel approach to the measurement of different in vitro leukaemic cell growth parameters: the use of PKH GL fluorescent probes. Leuk. Res. 1993; 17: 873–882
   Google Scholar
• Batard P., Monier M. N., Fortunel N., Ducos K., Sansilvestri-Morel P., Phan T., Hatzfeld A., Hatzfeld J. A. TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation. J. Cell Sci. 2000; 113(Pt 3)383–390
   PubMed Web of Science ®Google Scholar
• Becker H. M., Chen M., Hay J. B., Cybulsky M. I. Tracking of leukocyte recruitment into tissues of mice by in situ labeling of blood cells with the fluorescent dye CFDA SE. J. Immunol. Methods 2004; 286: 69–78
   PubMed Web of Science ®Google Scholar
• Becker M., Nitsche A., Neumann C., Aumann J., Junghahn I., Fichtner I. Sensitive PCR method for the detection and real-time quantification of human cells in xenotransplantation systems. Br. J. Cancer 2002; 87: 1328–1335
   Google Scholar
• Bonilla W. V., Geuking M. B., Aichele P., Ludewig B., Hengartner H., Zinkernagel R. M. Microchimerism maintains deletion of the donor cell-specific CD8+ T cell repertoire. J. Clin. Invest. 2006; 116: 156–162
   PubMedGoogle Scholar
• Boon T., Coulie P. G., Eynde B. J., Bruggen P. V. Human T Cell Responses against Melanoma. Annu. Rev. Immunol. 2006; 24: 175–208
   PubMed Web of Science ®Google Scholar
• Boutonnat J., Muirhead K. A., Barbier M., Mousseau M., Ronot X., Seigneurin D. PKH26 probe in the study of the proliferation of chemoresistant leukemic sublines. Anticancer Res. 1998; 18: 4243–4251
   PubMed Web of Science ®Google Scholar
• Brillard E., Pallandre J. R., Chalmers D., Ryffel B., Radlovic A., Seilles E., Rohrlich P. S., Pivot X., Tiberghien P., Saas P., Borg C. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes. Exp. Hematol. 2007; 35: 416–425
   PubMed Web of Science ®Google Scholar
• Brockhoff G., Fleischmann S., Meier A., Wachs F. P., Hofstaedter F., Knuechel R. Use of a mechanical dissociation device to improve standardization of flow cytometric cytokeratin DNA measurements of colon carcinomas. Cytometry 1999; 38: 184–191
   Google Scholar
• Chang A. E., Aruga A., Cameron M. J., Sondak V. K., Normolle D. P., Fox B. A., Shu S. Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2. J. Clin. Oncol. 1997; 15: 796–807
   PubMed Web of Science ®Google Scholar
• Chen Q., Fisher D. T., Clancy K. A., Gauguet J. M., Wang W. C., Unger E., Rose-John S., von Andrian U. H., Baumann H., Evans S. S. Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism. Nat. Immunol. 2006; 7: 1299–1308
   PubMed Web of Science ®Google Scholar
• Clement L. T. Isoforms of the CD45 common leukocyte antigen family: markers for human T-cell differentiation. J. Clin. Immunol. 1992; 12: 1–10
   PubMed Web of Science ®Google Scholar
• Cole D. J., Taubenberger J. K., Pockaj B. A., Yannelli J. R., Carter C., Carrasquillo J., Leitman S., Steinberg S. M., Rosenberg S. A., Yang Y. C. Histopathological analysis of metastatic melanoma deposits in patients receiving adoptive immunotherapy with tumor-infiltrating lymphocytes. Cancer Immunol. Immunother. 1994; 38: 299–303
   PubMed Web of Science ®Google Scholar
• Dhar N., Rao V., Tyagi A. K. Skewing of the Th1/Th2 responses in mice due to variation in the level of expression of an antigen in a recombinant BCG system. Immunol. Lett. 2003; 88: 175–184
   PubMed Web of Science ®Google Scholar
• Do Y., Ryu S., Nagarkatti M., Nagarkatti P. S. Role of death receptor pathway in estradiol-induced T-cell apoptosis. in vivo. Toxicol. Sci. 2002; 70: 63–72
   PubMed Web of Science ®Google Scholar
• Dudley M. E., Rosenberg S. A. Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat. Rev. Cancer 2003; 3: 666–675
   PubMed Web of Science ®Google Scholar
• Dudley M. E., Wunderlich J., Nishimura M. I., Yu D., Yang J. C., Topalian S. L., Schwartzentruber D. J., Hwu P., Marincola F. M., Sherry R., Leitman S. F., Rosenberg S. A. Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma. J. Immunother. 2001; 24: 363–373
   PubMed Web of Science ®Google Scholar
• Everhart L. P., Hauschka P. V., Prescott D. M. Measurement of growth and rates of incorporation of radioactive precursors into macromolecules of cultured cells. Meth. Cell. Biol. 1973; 7: 329–347
   Google Scholar
• Fidel P. L., Jr., Wolf N. A., KuKuruga M. A. T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the periphery. Infect. Immun. 1996; 64: 3793–3799
   PubMed Web of Science ®Google Scholar
• Fisher D. T., Chen Q., Appenheimer M. M., Skitzki J., Wang W. C., Odunsi K., Evans S. S. Hurdles to lymphocyte trafficking in the tumor microenvironment: implications for effective immunotherapy. Immunol. Invest. 2006; 35: 251–277
   PubMed Web of Science ®Google Scholar
• Ford A. L., Foulcher E., Goodsall A. L., Sedgwick J. D. Tissue digestion with dispase substantially reduces lymphocyte and macrophage cell-surface antigen expression. J. Immunol. Meth. 1996; 194: 71–75
   PubMed Web of Science ®Google Scholar
• Ford J. W., Welling T. H., 3rd, Stanley J. C., Messina L. M. PKH26 and 125I-PKH95: characterization and efficacy as labels for in vitro and in vivo endothelial cell localization and tracking. J. Surg. Res. 1996; 62: 23–28
   PubMed Web of Science ®Google Scholar
• Fremond C. M., Togbe D., Doz E., Rose S., Vasseur V., Maillet I., Jacobs M., Ryffel B., Quesniaux V. F. IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. J. Immunol. 2007; 179: 1178–1189
   PubMed Web of Science ®Google Scholar
• Fremond C. M., Yeremeev V., Nicolle D. M., Jacobs M., Quesniaux V. F., Ryffel B. Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J. Clin. Invest. 2004; 114: 1790–1799
   PubMed Web of Science ®Google Scholar
• Galon J., Costes A., Sanchez-Cabo F., Kirilovsky A., Mlecnik B., Lagorce-Pages C., Tosolini M., Camus M., Berger A., Wind P., Zinzindohoue F., Bruneval P., Cugnenc P. H., Trajanoski Z., Fridman W. H., Pages F. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313: 1960–1964
   PubMed Web of Science ®Google Scholar
• Gattinoni L., Powell D. J., Jr., Rosenberg S. A., Restifo N. P. Adoptive immunotherapy for cancer: building on success. Nat. Rev. Immunol. 2006; 6: 383–393
   PubMed Web of Science ®Google Scholar
• Gett A. V., Hodgkin P. D. Cell division regulates the T cell cytokine repertoire, revealing a mechanism underlying immune class regulation. Proc. Natl. Acad. Sci. USA 1998; 95: 9488–9493
   PubMed Web of Science ®Google Scholar
• Gilsbach R., Kouta M., Bonisch H., Bruss M. Comparison of in vitro and in vivo reference genes for internal standardization of real-time PCR data. Biotechniques 2006; 40: 173–177
   PubMed Web of Science ®Google Scholar
• Haeryfar S. M., Hoskin D. W. Thy-1: more than a mouse pan-T cell marker. J. Immunol. 2004; 173: 3581–3588
   PubMed Web of Science ®Google Scholar
• Hanson H. L., Donermeyer D. L., Ikeda H., White J. M., Shankaran V., Old L. J., Shiku H., Schreiber R. D., Allen P. M. Eradication of established tumors by CD8+ T cell adoptive immunotherapy. Immunity 2000; 13: 265–276
   PubMed Web of Science ®Google Scholar
• Hardy J., Edinger M., Bachmann M. H., Negrin R. S., Fathman C. G., Contag C. H. Bioluminescence imaging of lymphocyte trafficking. in vivo. Exp. Hematol. 2001; 29: 1353–1360
   PubMed Web of Science ®Google Scholar
• Hasbold J., Gett A. V., Rush J. S., Deenick E., Avery D., Jun J., Hodgkin P. D. Quantitative analysis of lymphocyte differentiation and proliferation in vitro using carboxyfluorescein diacetate succinimidyl ester. Immunol. Cell. Biol. 1999; 77: 516–522
   PubMedGoogle Scholar
• Hasbold J., Lyons A. B., Kehry M. R., Hodgkin P. D. Cell division number regulates IgG1 and IgE switching of B cells following stimulation by CD40 ligand and IL-4. Eur. J. Immunol. 1998; 28: 1040–1051
   Google Scholar
• Hellebrekers D. M., Castermans K., Vive E., Dings R. P., Hoebers N. T., Mayo K. H., Oude Egbrink M. G., Molema G., Fuks F., van Engeland M., Griffioen A. W. Epigenic regulation of tumor endothelial cell energy: Silencing of intracellular adhesion molecule-1 by histone modifications. Cancer Res. 2006; 66: 10110–10777
   Google Scholar
• Hodgkin P. D., Lee J. H., Lyons A. B. B cell differentiation and isotype switching is related to division cycle number. J. Exp. Med. 1996; 184: 277–281
   PubMedGoogle Scholar
• Holmes N. CD45: all is not yet crystal clear. Immunology 2006; 117: 145–155
   PubMed Web of Science ®Google Scholar
• Honig M. G., Hume R. I. Fluorescent carbocyanine dyes allow living neurons of identified origin to be studied in long-term cultures. J. Cell. Biol. 1986; 103: 171–187
   PubMed Web of Science ®Google Scholar
• Horan P. K., Melnicoff M. J., Jensen B. D., Slezak S. E. Fluorescent cell labeling for in vivo and in vitro cell tracking. Meth. Cell Biol. 1990; 33: 469–490
   PubMedGoogle Scholar
• Horan P. K., Slezak S. E. Stable cell membrane labelling. Nature 1989; 340: 167–168
   PubMed Web of Science ®Google Scholar
• Huang J., Khong H. T., Dudley M. E., El-Gamil M., Li Y. F., Rosenberg S. A., Robbins P. F. Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression. J. Immunother. 2005; 28: 258–267
   PubMed Web of Science ®Google Scholar
• Hugo P., Kappler J. W., Godfrey D. I., Marrack P. C. A cell line that can induce thymocyte positive selection. Nature 1992; 360: 679–682
   Google Scholar
• Hunter R. C., Beveridge T. J. Application of a pH-sensitive fluoroprobe (C‐SNARF-4) for pH microenvironment analysis in Pseudomonas aeruginosa biofilms. Appl. Environ. Microbiol. 2005; 71: 2501–2510
   PubMed Web of Science ®Google Scholar
• Ishizu A., Ishikura H., Nakamaru Y., Takeuchi E., Kimura C., Koike T., Yoshiki T. Thy-1 induced on rat endothelium regulates vascular permeability at sites of inflammation. Int. Immunol. 1995; 7: 1939–1947
   Google Scholar
• Itoh K., Sawamura Y., Hosokawa M., Kobayashi H. Scintigraphy with In-111 labeled lymphokine-activated killer cells of malignant brain tumor. Radiat. Med. 1988; 6: 276–281
   Google Scholar
• Jain R. K., Munn L. L., Fukumura D. Dissecting tumour pathophysiology using intravital microscopy. Nat. Rev. Cancer 2002; 2: 266–276
   PubMed Web of Science ®Google Scholar
• June C. H. Adoptive T cell therapy for cancer in the clinic. J. Clin. Invest. 2007; 117: 1466–1476
   PubMed Web of Science ®Google Scholar
• Killeen N. T-cell regulation: Thy-1 - hiding in full view. Curr. Biol. 1997; 7: R774–777
   PubMed Web of Science ®Google Scholar
• Kirk C. J., Hartigan-O'Connor D., Mule J. J. The dynamics of the T-cell antitumor response: chemokine-secreting dendritic cells can prime tumor-reactive T cells extranodally. Cancer Res. 2001; 61: 8794–8802
   PubMed Web of Science ®Google Scholar
• Klein A. B., Witonsky S. G., Ahmed S. A., Holladay S. D., Gogal R. M., Jr., Link L., Reilly C. M. Impact of different cell isolation techniques on lymphocyte viability and function. J. Immunoassay Immunochem. 2006; 27: 61–76
   PubMed Web of Science ®Google Scholar
• Koporc Z., Bigenzahn S., Blaha P., Fariborz E., Selzer E., Sykes M., Muehlbacher F., Wekerle T. Induction of mixed chimerism through transplantation of CD45-congenic mobilized peripheral blood stem cells after nonmyeloablative irradiation. Biol. Blood Marrow Transplant 2006; 12: 284–292
   Google Scholar
• Kreisel D., Krupnick A. S., Gelman A. E., Engels F. H., Popma S. H., Krasinskas A. M., Balsara K. R., Szeto W. Y., Turka L. A., Rosengard B. R. Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: an alternative mechanism of allorecognition. Nat. Med. 2002; 8: 233–239
   PubMed Web of Science ®Google Scholar
• Letarte M., Addis J., MacDonald M. E., Bernstein A., Lake P. Demonstration with monoclonal antibody of the glycoprotein nature of Thy-1.2 alloantigen. Can. J. Biochem. 1980; 58: 1026–1032
   Google Scholar
• Li Q., Carr A. L., Donald E. J., Skitzki J. J., Okuyama R., Stoolman L. M., Chang A. E. Synergistic effects of IL-12 and IL-18 in skewing tumor-reactive T‐cell responses towards a type 1 pattern. Cancer Res. 2005; 65: 1063–1070
   PubMed Web of Science ®Google Scholar
• Lyons A. B. Divided we stand: tracking cell proliferation with carboxyfluorescein diacetate succinimidyl ester. Immunol. Cell. Biol. 1999; 77: 509–515
   PubMedGoogle Scholar
• Lyons A. B. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J. Immunol. Meth. 2000; 243: 147–154
   PubMed Web of Science ®Google Scholar
• Lyons A. B., Parish C. R. Determination of lymphocyte division by flow cytometry. J. Immunol. Meth. 1994; 171: 131–137
   PubMed Web of Science ®Google Scholar
• Magg T., Albert M. H. Tracking cell proliferation using the far red fluorescent dye SNARF-1. Cytometry B Clin. Cytom. 2007, in press
   Google Scholar
• Mandl S., Schimmelpfennig C., Edinger M., Negrin R. S., Contag C. H. Understanding immune cell trafficking patterns via in vivo bioluminescence imaging. J. Cell Biochem. Suppl. 2002; 39: 239–248
   PubMedGoogle Scholar
• Matera G., Lupi M., Ubezio P. Heterogeneous cell response to topotecan in a CFSE-based proliferation test. Cytometry A 2004; 62: 118–128
   Google Scholar
• Matsui K., Wang Z., McCarthy T. J., Allen P. M., Reichert D. E. Quantitation and visualization of tumor-specific T cells in the secondary lymphoid organs during and after tumor elimination by PET. Nucl. Med. Biol. 2004; 31: 1021–1031
   Google Scholar
• Maus U. A., Janzen S., Wall G., Srivastava M., Blackwell T. S., Christman J. W., Seeger W., Welte T., Lohmeyer J. Resident alveolar macrophages are replaced by recruited monocytes in response to endotoxin-induced lung inflammation. Am. J. Respir. Cell Mol. Biol. 2006; 35: 227–235
   PubMed Web of Science ®Google Scholar
• Meijer S. L., Dols A., Urba W. J., Hu H. M., Smith I. J., Vetto J., Wood W., Doran T., Chu Y., Sayaharuban P., Alvord W. G., Fox B. A. Adoptive cellular therapy with tumor vaccine draining lymph node lymphocytes after vaccination with HLA-B7/beta2-microglobulin gene-modified autologous tumor cells. J. Immunother. (1997) 2002; 25: 359–372
   Google Scholar
• Mempel T. R., Henrickson S. E., Von Andrian U. H. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 2004; 427: 154–159
   PubMed Web of Science ®Google Scholar
• Mempel T. R., Pittet M. J., Khazaie K., Weninger W., Weissleder R., von Boehmer H., von Andrian U. H. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 2006; 25: 129–141
   Google Scholar
• Millrain M., Chandler P., Dazzi F., Scott D., Simpson E., Dyson P. J. Examination of HY response: T cell expansion, immunodominance, and cross-priming revealed by HY tetramer analysis. J. Immunol. 2001; 167: 3756–3764
   Google Scholar
• Mitchell M. S., Darrah D., Yeung D., Halpern S., Wallace A., Voland J., Jones V., Kan-Mitchell J. Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope. J. Clin. Oncol. 2002; 20: 1075–1086
   PubMed Web of Science ®Google Scholar
• Modi H., McDonald T., Chu S., Yee J. K., Forman S. J., Bhatia R. Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cells. Blood 2007; 109: 5411–5421
   PubMed Web of Science ®Google Scholar
• Morse M. A., Clay T. M., Lyerly H. K. Current status of adoptive immunotherapy of malignancies. Expert. Opin. Biol. Ther. 2002; 2: 237–247
   PubMed Web of Science ®Google Scholar
• Mukai S., Kjaergaard J., Shu S., Plautz G. E. Infiltration of tumors by systemically transferred tumor-reactive T lymphocytes is required for antitumor efficacy. Cancer Res. 1999; 59: 5245–5249
   PubMed Web of Science ®Google Scholar
• Muramatsu K., Kurokawa Y., You-Xin S., Bishop A. T., Doi K. Cell traffic between donor and recipient following rat limb allograft. J. Orthop. Res. 2005; 23: 181–187
   Google Scholar
• Oostendorp R. A., Audet J., Eaves C. J. High-resolution tracking of cell division suggests similar cell cycle kinetics of hematopoietic stem cells stimulated in vitro and in vivo. Blood 2000; 95: 855–862
   PubMed Web of Science ®Google Scholar
• Ottesen G. L., Christensen I. J., Larsen J. K., Hansen B., Andersen J. A. Tissue disaggregation for flow cytometric DNA analysis: comparison of fine-needle aspiration and an automated mechanical procedure. Cytometry 1996; 26: 65–68
   Google Scholar
• Parish C. R. Fluorescent dyes for lymphocyte migration and proliferation studies. Immunol. Cell Biol. 1999; 77: 499–508
   PubMed Web of Science ®Google Scholar
• Penninger J. M., Irie-Sasaki J., Sasaki T., Oliveira-dos-Santos A. J. CD45: new jobs for an old acquaintance. Nat. Immunol. 2001; 2: 389–396
   PubMed Web of Science ®Google Scholar
• Phan G. Q., Touloukian C. E., Yang J. C., Restifo N. P., Sherry R. M., Hwu P., Topalian S. L., Schwartzentruber D. J., Seipp C. A., Freezer L. J., Morton K. E., Mavroukakis S. A., White D. E., Rosenberg S. A. Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens. J. Immunother. 2003; 26: 349–356
   PubMed Web of Science ®Google Scholar
• Pockaj B. A., Sherry R. M., Wei J. P., Yannelli J. R., Carter C. S., Leitman S. F., Carasquillo J. A., Steinberg S. M., Rosenberg S. A., Yang J. C. Localization of 111indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response. Cancer 1994; 73: 1731–1737
   PubMed Web of Science ®Google Scholar
• Rannie G. H., Donald K. J. Estimation of the migration of thoracic duct lymphocytes to non-lymphoid tissues. A comparison of the distribution of radioactivity at intervals following i.v. transfusion of cells labelled with 3H, 14C, 75Se, 99mTc, 125I and 51Cr in the rat. Cell Tissue Kinet. 1977; 10: 523–541
   Google Scholar
• Rannie G. H., Thakur M. L., Ford W. L. An experimental comparison of radioactive labels with potential application to lymphocyte migration studies in patients. Clin. Exp. Immunol. 1977; 29: 509–514
   Google Scholar
• Rege T. A., Hagood J. S. Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses. Biochim. Biophys. Acta 2006; 1763: 991–999
   PubMed Web of Science ®Google Scholar
• Rogner U. C., Avner P. Congenic mice: cutting tools for complex immune disorders. Nat Rev Immunol 2003; 3: 243–252
   Google Scholar
• Rojewski M. T., Baldus C., Knauf W., Thiel E., Schrezenmeier H. Dual effects of arsenic trioxide (As2O3) on non-acute promyelocytic leukaemia myeloid cell lines: induction of apoptosis and inhibition of proliferation. Br. J. Haematol. 2002; 116: 555–563
   PubMed Web of Science ®Google Scholar
• Rosenberg S. A., Dudley M. E. Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes. Proc. Natl. Acad. Sci. USA 2004; 101(Suppl 2)14639–14645
   PubMed Web of Science ®Google Scholar
• Rosenberg S. A., Sherry R. M., Morton K. E., Scharfman W. J., Yang J. C., Topalian S. L., Royal R. E., Kammula U., Restifo N. P., Hughes M. S., Schwartzentruber D., Berman D. M., Schwarz S. L., Ngo L. T., Mavroukakis S. A., White D. E., Steinberg S. M. Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma. J. Immunol. 2005; 175: 6169–6176
   PubMed Web of Science ®Google Scholar
• Rosenberg S. A., Yang J. C., Robbins P. F., Wunderlich J. R., Hwu P., Sherry R. M., Schwartzentruber D. J., Topalian S. L., Restifo N. P., Filie A., Chang R., Dudley M. E. Cell transfer therapy for cancer: lessons from sequential treatments of a patient with metastatic melanoma. J. Immunother. (1997) 2003; 26: 385–393
   PubMed Web of Science ®Google Scholar
• Ryschich E., Schmidt J., Hammerling G. J., Klar E., Ganss R. Transformation of the microvascular system during multistage tumorigenesis. Int. J. Cancer 2002; 97: 719–725
   PubMed Web of Science ®Google Scholar
• Saga Y., Lee J. S., Saraiya C., Boyse E. A. Regulation of alternative splicing in the generation of isoforms of the mouse Ly-5 (CD45) glycoprotein. Proc. Natl. Acad. Sci. USA 1990; 87: 3728–3732
   PubMedGoogle Scholar
• Salvi A., Quillan J. M., Sadee W. Monitoring intracellular pH changes in response to osmotic stress and membrane transport activity using 5-chloromethylfluorescein. AAPS Pharm. Sci. 2002; 4: E21
   Google Scholar
• Samlowski W. E., Robertson B. A., Draper B. K., Prystas E., McGregor J. R. Effects of supravital fluorochromes used to analyze the in vivo homing of murine lymphocytes on cellular function. J. Immunol. Meth. 1991; 144: 101–115
   PubMed Web of Science ®Google Scholar
• Seksek O., Bolard J. Nuclear pH gradient in mammalian cells revealed by laser microspectrofluorimetry. J. Cell Sci. 1996; 109(Pt 1)257–262
   Google Scholar
• Seksek O., Henry-Toulme N., Sureau F., Bolard J. SNARF-1 as an intracellular pH indicator in laser microspectrofluorometry: a critical assessment. Anal. Biochem. 1991; 193: 49–54
   PubMedGoogle Scholar
• Selvaraj R. K., Geiger T. L. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta. J. Immunol. 2007; 179: 11, p following 1390.
   PubMedGoogle Scholar
• Skitzki J., Craig R. A., Okuyama R., Knibbs R. N., McDonagh K., Chang A. E., Stoolman L. M. Donor cell cycling, trafficking, and accumulation during adoptive immunotherapy for murine lung metastases. Cancer Res. 2004; 64: 2183–2191
   PubMed Web of Science ®Google Scholar
• Spotl L., Sarti A., Dierich M. P., Most J. Cell membrane labeling with fluorescent dyes for the demonstration of cytokine-induced fusion between monocytes and tumor cells. Cytometry 1995; 21: 160–169
   PubMedGoogle Scholar
• Su H., Chang D. S., Gambhir S. S., Braun J. Monitoring the antitumor response of naive and memory CD8 T cells in RAG1-/- mice by positron-emission tomography. J. Immunol. 2006; 176: 4459–4467
   Google Scholar
• Tanigawa K., Takeshita N., Craig R. A., Phillips K., Knibbs R. N., Chang A. E., Stoolman L. M. Tumor-specific responses in lymph nodes draining murine sarcomas are concentrated in cells expressing P-selectin binding sites. J. Immunol. 2001; 167: 3089–3098
   Google Scholar
• Teare G. F., Horan P. K., Slezak S. E., Smith C., Hay J. B. Long-term tracking of lymphocytes in vivo: the migration of PKH-labeled lymphocytes. Cell Immunol. 1991; 134: 157–170
   PubMed Web of Science ®Google Scholar
• Thanarajasingam U., Sanz L., Diaz R., Qiao J., Sanchez-Perez L., Kottke T., Thompson J., Chester J., Vile R. G. Delivery of CCL21 to metastatic disease improves the efficacy of adoptive T-cell therapy. Cancer Res. 2007; 67: 300–308
   Google Scholar
• Thiede C. Diagnostic chimerism analysis after allogeneic stem cell transplantation: new methods and markers. Am. J. Pharmacogen. 2004; 4: 177–187
   PubMedGoogle Scholar
• Thompson B. S., Mitchell T. C. Measurement of daughter cell accumulation during lymphocyte proliferation in vivo. J Immunol Methods 2004; 295: 79–87
   Google Scholar
• Tromp S. C., oude Egbrink M. G., Dings R. P., van Velzen S., Slaaf D. W., Hillen H. F., Tangelder G. J., Reneman R. S., Griffioen A. W. Tumor angiogenesis factors reduce leukocyte adhesion in vivo. Int. Immunol. 2000; 12: 671–676
   Google Scholar
• Trowbridge I. S., Thomas M. L. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu. Rev. Immunol. 1994; 12: 85–116
   PubMed Web of Science ®Google Scholar
• von Andrian U. H. Intravital microscopy of the peripheral lymph node microcirculation in mice. Microcirculation 1996; 3: 287–300
   PubMedGoogle Scholar
• Wallace P. K., Palmer L. D., Perry-Lalley D., Bolton E. S., Alexander R. B., Horan P. K., Yang J. C., Muirhead K. A. Mechanisms of adoptive immunotherapy: improved methods for in vivo tracking of tumor-infiltrating lymphocytes and lymphokine-activated killer cells. Cancer Res. 1993; 53: 2358–2367
   PubMed Web of Science ®Google Scholar
• Wang L. X., Chen B. G., Plautz G. E. Adoptive immunotherapy of advanced tumors with CD62 L-selectin(low) tumor-sensitized T lymphocytes following ex vivo hyperexpansion. J. Immunol. 2002; 169: 3314–3320
   PubMedGoogle Scholar
• Weijer S., Leemans J. C., Florquin S., Shimizu T., Ishii S., van der Poll T. Host response of platelet-activating factor receptor-deficient mice during pulmonary tuberculosis. Immunology 2003; 109: 552–556
   Google Scholar
• Weston S. A., Parish C. R. New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy. J. Immunol. Meth. 1990; 133: 87–97
   PubMed Web of Science ®Google Scholar
• Wherry E. J., Teichgraber V., Becker T. C., Masopust D., Kaech S. M., Antia R., von Andrian U. H., Ahmed R. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 2003; 4: 225–234
   PubMed Web of Science ®Google Scholar
• Whitaker J. E., Haugland R. P., Prendergast F. G. Spectral and photophysical studies of benzo[c]xanthene dyes: dual emission pH sensors. Anal. Biochem. 1991; 194: 330–344
   PubMed Web of Science ®Google Scholar
• Wieder E. D., Hang H., Fox M. H. Measurement of intracellular pH using flow cytometry with carboxy-SNARF-1. Cytometry 1993; 14: 916–921
   PubMedGoogle Scholar
• Wiltrout R. H., Gorelik E., Brunda M. J., Holden H. T., Herberman R. B. Assessment of in vivo natural antitumor resistance and lymphocyte. Migration in mice: comparison of 125I-iododeoxyuridine with 111indium-oxine and 51chromium as cell labels. Cancer Immunol. Immunother. 1983; 14: 172–179
   Google Scholar
• Wright K. O., Murray D. A., Crispe N. I., Pierce R. H. Quantitative PCR for detection of the OT-1 transgene. BMC Immunol. 2005; 6: 20
   Google Scholar
• Wu N. Z., Klitzman B., Dodge R., Dewhirst M. W. Diminished leukocyte-endothelium interaction in tumor microvessels. Cancer Res. 1992; 52: 4265–4268
   PubMed Web of Science ®Google Scholar
• Yee C., Riddell S. R., Greenberg P. D. In vivo tracking of tumor-specific T cells. Curr. Opin. Immunol. 2001; 13: 141–146
   PubMed Web of Science ®Google Scholar
• Yokouchi H., Chamoto K., Wakita D., Noguchi D., Yamazaki K., Dosaka-Akita H., Nishimura M., Ikeda H., Nishimura T. Tetramer-blocking assay for defining antigen-specific cytotoxic T lymphocytes using peptide-MHC tetramer. Cancer Sci. 2006; 97: 148–154
   Google Scholar
• Zebedee S. L., Barritt D. S., Raschke W. C. Comparison of mouse Ly5a and Ly5b leucocyte common antigen alleles. Dev. Immunol. 1997; 1: 243–254
   Google Scholar